Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phase.
Koiji SasakiHagop M KantarjianSusan M O'BrienFarhad RavandiMarina KonoplevaGautam BorthakurGuillermo Garcia-ManeroWilliam WierdaNaval G DaverAlessandra FerrajoliKoichi TakahashiPreetesh JainMary Beth RiosSherry PierceElias J JabbourJorge E CortesPublished in: Cancer (2017)
This model proposes optimal values that predict the highest probability of reaching such a goal. These values can be used to guide therapy when a sustained MR4.5 is the objective. Cancer 2018;124:1160-8. © 2017 American Cancer Society.